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Teratogenic levels of retinoic acid (RA) signaling can cause seemingly contradictory phenotypes in-
dicative of both increases and decreases of RA signaling. However, the mechanisms underlying these
contradictory phenotypes are not completely understood. Here, we report that using a hyperactive RA
receptor to enhance RA signaling in zebraﬁsh embryos leads to defects associated with gain and loss of
RA signaling. While the gain-of-function phenotypes arise from an initial increase in RA signaling, using
genetic epistasis analysis we found that the loss-of-function phenotypes result from a clearing of em-
bryonic RA that requires a rapid and dramatic increase in cyp26a1 expression. Thus, the sensitivity of
cyp26a1 expression to increased RA signaling causes an overcompensation of negative feedback and loss
of embryonic RA signaling. Additionally, we used blastula transplantation experiments to test if Cyp26a1,
despite its cellular localization, can limit RA exposure to neighboring cells. We ﬁnd that enhanced
Cyp26a1 expression limits RA signaling in the local environment, thus providing the ﬁrst direct evidence
that Cyp26 enzymes can have cell non-autonomous consequences on RA levels within tissues. Therefore,
our results provide novel insights into the teratogenic mechanisms of RA signaling and the cellular
mechanisms by which Cyp26a1 expression can shape a RA gradient.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
Retinoic acid (RA) is the most abundant metabolic product of
vitamin A in vertebrates (Duester, 2008; Niederreither et al., 2002;
Niederreither and Dolle, 2008; Theodosiou et al., 2010). Normal
development requires a proper balance of RA signaling, which is
maintained through positive and negative feedback mechanisms
(D'Aniello et al., 2013; Dobbs-McAuliffe et al., 2004; Lee et al.,
2012; Niederreither et al., 1997; Reijntjes et al., 2005; Schilling
et al., 2012; White et al., 2007). The most robust feedback me-
chanism dictating RA levels within the embryo acts through con-
trolling RA degradation (Reijntjes et al., 2005; White et al., 2007).
A conserved feature of RA signaling in vertebrate embryos is that
increased RA induces expression of Cyp26a1 (Loudig et al., 2005;
Pozzi et al., 2006), which is the major embryonic RA degrading
enzyme. Direct transcriptional activation through RA receptors
(RARs) promotes the induction of cyp26a1 expression, whichaxman).
emistry, Consiglio Nazionale
p, Napoli, Italy.allows for it to rapidly respond to ﬂuctuations in RA levels (Hu
et al., 2008; Kashyap et al., 2013; Lalevee et al., 2011; Li et al., 2012;
Loudig et al., 2000, 2005). Although cyp26a1 is potentially the
most sensitive gene that responds to modulation of RA within the
early embryo due its direct transcriptional regulation (D'Aniello
et al., 2013; Hu et al., 2008; Kashyap et al., 2013; Lalevee et al.,
2011; Li et al., 2012; Loudig et al., 2005; Pozzi et al., 2006; White
et al., 2007), ﬂuctuations of RA also affect the expression of the RA
producing enzymes retinol dehydrogenase 10 (Rdh10), which
generates the RA precursor retinal from retinol, and retinaldehyde
dehydrogenase 1a2 (Aldh1a2), which generates RA from retinal
(Dobbs-McAuliffe et al., 2004; Farjo et al., 2011). In contrast to RA
positively regulating Cyp26a1 expression, RA negatively regulates
rdh10 and aldh1a2 expression (Dobbs-McAuliffe et al., 2004; Nie-
derreither et al., 1997; Sandell et al., 2012; Sandell et al., 2007).
While the RA feedback mechanisms exist to help maintain RA
signaling levels within an appropriate range, recent work has
suggested that increases or decreases in RAR signaling can lead to
complicated phenotypes that have aspects of defects observed in
both gain and loss of RA signaling (Lee et al., 2012; Waxman and
Yelon, 2011). However, the mechanisms underlying these contra-
dictory phenotypes are not yet completely understood.
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our understanding of how RA functions during vertebrate devel-
opment. Within the early vertebrate embryo, RA acts as a mor-
phogen creating a gradient that is required for patterning the
anterior–posterior axis (Kudoh et al., 2002; Maves and Kimmel,
2005; White et al., 2007). Recent studies have allowed the visua-
lization of an RA gradient in zebraﬁsh embryos (Shimozono et al.,
2013; White et al., 2007), but the mechanism underlying RA gra-
dient formation in vertebrates has been highly debated. Models
have been proposed where Cyp26a1 helps generate an RA gradient
through cell-autonomous and cell non-autonomous mechanisms
(Hernandez et al., 2007; Maves and Kimmel, 2005; Sirbu et al.,
2005; Uehara et al., 2007; White et al., 2007; White and Schilling,
2008). The strictly cell autonomous models proposed that the RA
gradient is created through the differential expression and dura-
tion of Cyp26 enzymes within tissues (Hernandez et al., 2007;
Maves and Kimmel, 2005; Sirbu et al., 2005). This model is based
on work examining hindbrain patterning in zebraﬁsh and mice,
which found that spatiotemporal differences in the location of
Cyp26 enzymes correlates with the patterning of distinct rhom-
bomeres (Hernandez et al., 2007; Maves and Kimmel, 2005; Sirbu
et al., 2005). In contrast to the strictly cell autonomous model,
Uehara et al. (2007) ﬁrst suggested Cyp26 enzymes may have cell
non-autonomous consequences on RA signaling based on the ob-
servation that loss of Cyp26a1 and Cyp26c1 in the head me-
senchyme leads to changes in the adjacent neuroectoderm. Simi-
larly, in zebraﬁsh, Martin and Kimelman (2010) found that
Cyp26a1 does not have cell autonomous roles within mesodermal
progenitor pool, suggesting non-autonomous functions. Further-
more, recent work from our lab has suggested that loss of Cyp26
enzymes can have cell non-autonomous consequences in pat-
terning the cardiovascular progenitor ﬁelds within the anterior
lateral plate mesoderm (Rydeen and Waxman, 2014). Additionally,
using computational modeling, White et al. (2007) proposed a
model in zebraﬁsh embryos where the embryonic RA gradient is
shaped through self-enhanced degradation by promoting Cyp26a1
expression, in effect arguing that Cyp26a1 may have cell autono-
mous and cell non-autonomous consequences in shaping the
embryonic RA gradient. Despite the arguments for and against
Cyp26 enzymes being able to control RA levels in the environ-
ment, a direct test of cell non-autonomous effects of Cyp26 en-
zymes on RA levels within the embryo has not been performed.
Here, we sought to better understand the feedback mechan-
isms underlying the contradictory gain and loss of function phe-
notypes seen from teratogenic increases of RA signaling in verte-
brate embryos and determine the cellular mechanisms that con-
tribute to establishing the embryonic RA gradient. To do so, we
employed a RA responsive hyperactive RAR, which induces con-
tradictory phenotypes consistent with gain and loss of RA signal-
ing (Waxman and Yelon, 2011), similar to what is found with acute
RA treatment in mice (Lee et al., 2012). Importantly, we ﬁnd that
the loss of RA signaling within the early zebraﬁsh embryo requires
the rapid induction and persistent expression of Cyp26a1. More-
over, Cyp26a1 is required for the RA loss of function phenotypes,
as cyp26a1/giraffe (gir) mutants injected with the hyperactive RAR
do not display phenotypes consistent with loss of RA signaling.
Importantly, we use the induction of Cyp26a1 in this model in
combination with a transgenic RA sensor line to directly test the
hypothesis that enhanced Cyp26a1 is required to affect the
amount of RA in the local environment. Our studies are the ﬁrst to
directly demonstrate that Cyp26a1 can act as a sink that has cell
non-autonomous consequences on local RA levels. Therefore, our
work provides novel insight into the consequences of excessive
embryonic RA signaling and the mechanisms that contribute to RA
gradient formation.2. Materials and methods
2.1. Zebraﬁsh husbandry and transgenic lines
Zebraﬁsh were raised and housed under standard conditions
(Westerﬁeld, 2000). The following transgenic lines were used: Tg
(-5.1myl7:DsRed-NLS) (Mably et al., 2003), Tg(βactin:GDBD-RLBD);
(UAS:EGFP) (Mandal et al., 2013), Tg(βactin:GDBD-RLBD);(UAS:
mCherry) (Mandal et al., 2013) and Tg(hsp70l:EGFP-VP-RAR). The
cyp26a1/giraffe mutant was used (Emoto et al., 2005).
2.2. mRNA synthesis
The cyp26a1 gene was cloned into pCS-DEST1 using the Tol2
Gateway kit (Invitrogen), as previously described (Villefranc et al.,
2007). Cyp26a1 mRNA was synthesized using the Sp6 Message
Machine Transcription kit (Ambion).
2.3. mRNA and MO injections
All injections were performed at the one cell stage. 150 pg vp-
rar mRNA was injected. The VP-RAR construct was reported pre-
viously as RARab-ΔAvp (Waxman and Yelon, 2011). In this con-
struct, the VP16 activation domain replaces the A terminal domain
of the zebraﬁsh RARab. 30 pg of membrane-rfp (mrfp) mRNA (Iioka
et al., 2004) was injected into host embryos for transplantation
experiments. Cyp26a1 mRNA was injected at 500 pg as previously
described (Kudoh et al., 2002). Previously published cyp26a1 MOs
were injected using a cocktail of 2–4 ng cyp26a1 MO1 and 1–2 ng
cyp26a1 MO2, as well as 3 ng p53 MO to combat non-speciﬁc cell
death (D'Aniello et al., 2013; Rydeen and Waxman, 2014).
2.4. In situ hybridization
Standard procedure was used for all whole mount ISH as de-
scribed previously (Oxtoby and Jowett, 1993). All probes were re-
ported previously: cyp26a1 (ZDB-GENE-990415-44), rdh10a (ZDB-
GENE-070112-2242), aldh1a2 (ZDB-GENE-001101-3), six6b (ZDB-
GENE-050522-308), eng2a (ZDB-GENE-980526-167), egr2b (for-
merly krox20; ZDB-GENE-980526-283), myod1 (formerly myoD;
ZDB-GENE-980526-561); hoxb5b (ZDB-GENE-000823-6), cyp26b1
(ZDB-GENE-030131-2908), cyp26c1 (ZDB-GENE-050714-2), nkx2.5
(ZDB-GENE-980526-321), egfp (accession number: JQ064510.1),
and mCherry (accession number: JN795134.1). For experiments
using the gir mutants, genotyping was done as described pre-
viously (Emoto et al., 2005).
2.5. Reverse transcriptase quantitative PCR (RT-qPCR)
RT-qPCR was performed as has been previously described
(D'Aniello et al., 2013; Rydeen and Waxman, 2014). Whole embryo
RNA was obtained from pooled groups of 30 embryos, which were
homogenized in Trizol (Ambion) and isolated using Purelink RNA
Microkit (Invitrogen). cDNA synthesis was performed with 1 mg
RNA using the ThermoScript Reverse Transcriptase kit (Invitrogen).
Quantitative real time PCR was performed with Power SYBR Green
PCR Master Mix (Applied Biosystems) using standard PCR condi-
tions in a BioRad CFX-96 PCR machine. Expression levels were
standardized to β-actin expression and analyzed using the 2ΔΔCT
Livak Method. Primer sequences for cyp26a1, rdh10a, aldh1a2,
hoxb5b, amhc, vmhc, and myl7 are provided in Supplemental
Table 1.
2.6. Generation of Tg(hsp70l:EGFP-VP-RAR)ci104 line
The Tg(hsp70l:EGFP-VP-RAR)ci104 line was made using standard
Table 1
Summary of injection cocktails for transplantation experiments.
Transplant experiment Donor Host
Sensor- control 1 ng Cascade Blue 30 pg mrfp mRNA
Sensor- vp-rar 1 ng Cascade Blue 150 pg vp-rar mRNA
30 pg mrfp mRNA
Sensor- Cyp26a1 MOs 1 ng Cascade Blue 30 pg mrfp mRNA
cyp26a1 MO cocktail
Sensor- vp-rarþCyp26a1 1 ng Cascade Blue 150 pg vp-rar mRNA
cyp26a1 MO cocktail
Cyp26a1 MOs- vp-rar 1 ng Cascade Blue 150 pg vp-rar mRNA
30 g mrfp mRNA cyp26a1 MO cocktail
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3′-entry clones were used (Kwan et al., 2007). For the middle entry
clone, an EGFP N-terminal fusion was made to the VP-RAR con-
struct using PCR, it was cloned into pCS2pþ , and mRNAwas made.
After conﬁrming that this fusion protein retained ﬂuorescence and
functioned similarly to the native VP-RAR after mRNA injection at
the one cell stage, the EGFP-VP-RAR fusion was cloned into a
middle entry vector and then assembled into the previously re-
ported pDestTol2p2A-αcry:Dsred destination vector (Mandal et al.,
2013). Stable transgenic lines were then made and assayed for
ﬂuorescence and function after heat-shock. Multiple founders
were identiﬁed that yielded the inducible transgene in a Mende-
lian ratio. The line selected for experiments yielded the brightest
GFP expression after heat-shock.
2.7. Heat-shock experiments
Heat-shock experiments were performed using embryosFig. 1. VP-RAR promotes a prolonged increase in cyp26a1 expression. (A–H) Wholemo
embryos compared to WT siblings at 30% epiboly through 14 s stage. (I–P) ISH of RA syn
mRNA injected embryos compared to WT at the shield stage (I,J,M,N), with dramatic
diencephalon), eng2a (midbrain–hindbrain boundary), egr2b (rhombomeres 3 and 5), an
lack of eng2a and severely reduced six6b and rhombomere 3 (anterior egr2b) in vp-rar m
rhombomere 3. (S,T) Expression of hoxb5b is decreased in the lateral plate mesoderm
compared to WT siblings. (U) RT-qPCR with cyp26a1, rdh10a, aldh1a2, and hoxb5b exp
Asterisks indicate statistically different from control (po0.05) using Student's t-test.obtained from hemizygous Tg(hsp70l:EGFP-VP-RAR) adults crossed
to either hemizygous Tg(βactin:GDBD-RLBD);(UAS:mCherry) or WT
adults. Embryos were maintained at 28.5 °C until 24 hpf when
they were heat-shocked at 37 °C for 30 min in a BioRad PCR ma-
chine. Transgenic embryos were then sorted from their non-
transgenic siblings by the presence of GFP.2.8. Cell counts
Immunohistochemistry, cell counts, and statistical analysis
were performed as previously described (Waxman et al., 2008).2.9. Blastula transplantation experiments
Transplantation experiments were performed similar to what
has been previously described (Waxman et al., 2008). For all ex-
periments Tg(βactin:GDBD-RLBD);(UAS:EGFP) donor embryos were
injected with 1 ng Cascade Blue-dextran tracer (Life Technologies).
Amounts of cyp26a1 MOs, mrfp and vp-rar mRNAs are indicated in
Table 1. Embryos were chemically dechorionated using Pronase
(Sigma). At sphere stage, approximately 30 cells from donor em-
bryos were transplanted into the marginal zone of host embryos.
Following transplantation, host and donor embryos were trans-
ferred to 24 well dishes with one embryo per well and maintained
at 28.5 °C. Donors were maintained to conﬁrm the potential of the
donor RA sensor cells to respond to RA. At 20 hpf, host embryos
were screened for donor cell contribution and GFP expression,
then imaged using a Nikon A1 confocal microscope. Statistics were
performed using a chi-squared test where po0.05 was considered
statistically signiﬁcant.unt ISH shows a dramatic increase in cyp26a1 expression in vp-rar mRNA injected
thesizing genes rdh10a and aldh1a2 shows modestly decreased expression in vp-rar
decreases found by the tailbud stage (K,L,O,P). (Q,R) ISH using a six6b (anterior
d myod1 (adaxial cells and somites) cocktail (referred to here at sekm cktl) shows a
RNA injected compared to WT. Arrows in R indicate the loss of eng2a and reduced
(brackets) and anterior spinal cord (arrows) in vp-rar mRNA injected embryos
ression in vp-rar mRNA injected embryos at the shield (sh) through 24 s stages.
Fig. 2. VP-RAR expression promotes increased cardiomyocyte number. (A, B) The
hearts from vp-rar mRNA injected Tg(myl7:DsRed-NLS) embryos are enlarged re-
lative to siblings. Images are frontal views. Red alone indicates ventricular cells.
Atrium is indicated in green (S46 antibody). (C) Cell counts of vp-rarmRNA injected
embryos at 48 hpf reveal an increase in both atrial and ventricular cardiomyocytes
relative to control sibling embryos. Control n¼10. Vp-rar injected n¼7. (D) RT-qPCR
at 48 hpf of cardiac markers amhc, vmhc, and myl7 shows increased expression in
vp-rar mRNA injected embryos compared to control siblings. Asterisks indicate
statistically different from control (po0.05) using Student's t-test.
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3.1. A hyperactive RAR can induce both increases and decreases in
RA signaling
Previous studies have indicated that increases in RA signaling
can induce overtly contradictory phenotypes. Our previous work
using a RA dependent hyperactive RAR (VP-RAR) can induce both
gain and loss of RA signaling phenotypes (Waxman and Yelon,
2011), similar to a pulsed RA treatment in mice (Lee et al., 2012),
but the mechanisms underlying how enhanced RA signaling pro-
duces these seemingly contradictory phenotypes are not com-
pletely understood. To determine if inappropriate modulation of
RA metabolizing enzyme expression underlies both gain and loss
of RA signaling phenotypes in zebraﬁsh embryos, we injected
zebraﬁsh embryos at the one-cell stage with vp-rar mRNA and
assayed the expression of the major embryonic RA producing
enzymes rdh10a and aldh1a2 and the RA degrading enzyme
cyp26a1. We found by in situ hybridization (ISH) that vp-rar
mRNA-injected embryos had a rapid and maintained early global
induction of cyp26a1 expression (Fig. 1A–D). The increased ex-
pression of cyp26a1 in vp-rar mRNA-injected embryos was overtly
detectable by in situ hybridization (ISH) through the 14 somite
(s) stage (Fig. 1E–H). Assaying cyp26a1 expression with RT-qPCR
demonstrated a dramatic induction by the shield stage, which
gradually attenuates by 24 h post-fertlization (hpf) (Fig. 1U). In
contrast to the effects on cyp26a1, injection of vp-rar mRNA pro-
duced a reduction in the expression domains of the RA synthe-
sizing enzymes rdh10a and aldh1a2 by the tailbud stage (Fig. 1I–P).
RT-qPCR indicated that aldh1a2 expression was decreased by the
shield (sh) stage, while the expression of both rdh10a and aldh1a2
was decreased by the tailbud (tb) stage and then gradually atte-
nuated to normal by 16 s (Fig. 1U). Together, these data indicate
that enhancing the endogenous RA signaling with the hyperactive
RAR can produce two effects on the expression of the RA meta-
bolizing machinery: ﬁrst, a dramatic, rapid and prolonged induc-
tion of cyp26a1; second, a slightly more delayed and more tran-
sient repression of the expression of RA producing enzymes.
In vertebrates, early increases in RA signaling lead to reduction
of head size and anterior hindbrain along with loss of the midbrain
hindbrain boundary (MHB) (Hernandez et al., 2007; Waxman and
Yelon, 2011; White et al., 2007; White and Schilling, 2008). We
found that vp-rar mRNA injected embryos exhibited smaller head
size and loss of the MHB (Fig. 1Q, R), consistent with increases in
RA signaling. However, in contrast with the effects observed on the
brain, vp-rar mRNA injected embryos also had loss of hoxb5b
(Fig. 1S, T), a direct target of RA that initiates later (D'Aniello et al.,
2013; Waxman et al., 2008), which is a phenotype indicative of
decreased RA signaling. Moreover, decreased hoxb5b expression
persisted through the 20 s stage (Fig. 1S, T, U). Therefore, our data
suggest that enhancing RA signaling with the hyperactive RAR
promotes a rapid conversion from increased RA signaling to de-
creased RA signaling along the anterior–posterior axis of the
embryos.
To better understand the consequences of the transition from
increased to decreased RA signaling, we examined cardiomyocyte
development. Increases in RA signaling can inhibit cardiomyocyte
speciﬁcation, while decreases in RA signaling can promote cardi-
omyocyte speciﬁcation (Keegan et al., 2005; Rydeen and Waxman,
2014; Waxman and Yelon, 2009). Interestingly, examining heart
morphology, cell number, and cardiomyocyte marker expression,
we found that the hearts of vp-rar mRNA-injected
Tg(-5.1myl7:DsRed-NLS)f2 embryos (Mably et al., 2003) were en-
larged, had increased cell number, and increased cardiomyocyte
marker expression at 48 hpf (Fig. 2A–D), which are all phenotypes
associated with loss of RA signaling (Waxman et al., 2008).Therefore, these results suggest that vp-rar mRNA injection pro-
motes defects from inverse levels of RA signaling: ﬁrst, it promotes
early teratogenic increases in RA signaling that inhibit anterior
brain development; second, slightly later speciﬁed, more-posterior
tissues, including the cardiac progenitors, sense there is a loss of
RA signaling.
3.2. Cyp26a1 is necessary to produce a loss of RA signaling after
enhanced RA signaling
Since we found that there was a strong induction of cyp26a1
expression coupled with a loss of RA producing enzymes, we next
wanted to determine if the loss of RA signaling was due to a loss of
embryonic RA. To do this, we used our recently reported trans-
genic RA sensor line, Tg(βactin:GDBD-RLBD);(UAS:EGFP) (Mandal
et al., 2013), which employs a ubiquitously expressed Gal4 DNA
binding domain fused to a RAR ligand binding domain to drive
UAS:EGFP in the presence of RA. Tg(βactin2:GDBD-RLBD);(UAS:
EGFP) embryos injected with vp-rar mRNA had dramatically re-
duced egfp expression compared to WT siblings (Fig. 3A, B). To
determine if this feedback mechanism is also sufﬁcient to produce
a reduction in embryonic RA at later stages of development, we
created a heat-shock inducible vp-rar transgenic line –
Tg(hsp70l:EGFP-VP-RAR)ci104 (Supplemental Fig. 1). Heat-shocking
the Tg(hsp70l:EGFP-VP-RAR) line at 26 hpf enhances cyp26a1 and
represses rdh10a by 4 h post-heat shock similar to what we ob-
served at earlier stages (Supplemental Fig. 2). To examine the ef-
fects on embryonic RA, hemizygous Tg(hsp70l:EGFP-VP-RAR) ﬁsh
Fig. 3. Embryonic RA is decreased in VP-RAR expressing embryos. (A, B) vp-rar
mRNA injected into Tg(βactin:GDBD-RLBD);(UAS:EGFP) embryos shows signiﬁcant
loss of GFP expression indicating embryonic RA is reduced compared to WT. 25%
(n¼7 of 28) of control embryos from the Tg(βactin:GDBD-RLBD);(UAS:EGFP) out-
crossed to a WT adult showed strong RA sensor expression, while 22% (n¼8 of 37)
of vp-rar mRNA injected embryos had dramatically reduced RA sensor expression.
(C,D) RA levels are greatly diminished after heat-shock induction of the egfp-vp-rar
transgene in Tg(βactin:GDBD-RLBD);(UAS:mCherry) embryos compared to siblings
without the heat-shock inducible transgene.
Fig. 4. Cyp26a1 is required for induction of RA loss of function. (A,C) Gir / em-
bryos have expanded hoxb5b expression relative to their siblings. (B,D) Gir /
embryos injected with vp-rar mRNA have expanded hoxb5b expression, while the
remaining girþ /? Embryos lose hoxb5b expression. (E–H) ISH for the sekm cktl and
rdh10a in embryos from a girþ / adult cross show that vp-rar mRNA injected
embryos still showed brain defects and rdh10a expression was unchanged.
Fig. 5. Cyp26a1 is required for increased cardiac speciﬁcation in VP-RAR expressing
embryos. (A–D) ISH of nkx2.5 in embryos obtained from a girþ / adult cross with
and without vp-rar mRNA injection. nkx2.5 expression is increased in vp-rar mRNA
injected girþ /? embryos compared to their uninjected siblings, while vp-rar mRNA
injected gir / embryos show no difference compared to uninjected gir/ sib-
lings. (E) Quantiﬁcation of nkx2.5 expression length. Asterisks indicate statistically
different from control (po0.05) using Student's t-test.
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ry) ﬁsh. Embryos were then selected for mCherry expression prior
to heat-shock at 24 hpf. Consistent with injection of the vp-rar
mRNA, we found that heat-shocked Tg(hs70l:EGFP-VP-RAR); (βac-
tin:GDBD-RLBD);(UAS:mCherry) embryos had visibly less mCherry
expression by four hours after heat-shock (Fig. 3C, D), suggesting a
rapid turnover and loss of RA signaling. Therefore, our results
show that enhanced RAR transcriptional activity that initially re-
sults in enhanced RA signaling subsequently produces loss of
embryonic RA.
We next wanted to understand what was causing the loss of
embryonic RA. We reasoned that the loss could be caused by the
increased Cyp26a1, decreased Rdh10a and Aldh1a2, or the com-
bined effects on these enzymes. However, since we observed a
more dramatic and prolonged increase in cyp26a1 expression after
enhancing RA signaling with the hyperactive RAR, we focused on
the hypothesis that increased Cyp26a1 is required to deplete the
embryonic RA. To test this hypothesis, we injected vp-rar mRNA
into embryos from heterozygous cyp26a1/gir mutant adult crosses
(Emoto et al., 2005) and examined hoxb5b expression. We found
that gir mutants injected with vp-rar mRNA had an expansion of
hoxb5b expression, similar to uninjected siblings (Fig. 4A–D), in-
dicating that Cyp26a1 induction contributes to the loss of RA
signaling phenotype. To further corroborate this hypothesis, we
examined if the increased heart size, due to an increase in cardi-
omyocyte speciﬁcation, was also dependent on cyp26a1 expres-
sion. Consistent with the effect on hoxb5b expression, we found
that gir mutants injected with vp-rar mRNA did not exhibit an
increase in the expression of the cardiomyocyte marker nkx2.5,
which was found in vp-rar mRNA injected WT siblings (Fig. 5A–E),
suggesting that increased cardiomyocyte speciﬁcation is Cyp26a1
dependent. However, cyp26a1 deﬁciency in vp-rar mRNA injected
embryos failed to rescue anterior brain defects and did not result
in positive or negative effects on rdh10a expression at these later
stages (Fig. 4E–H), suggesting that the early anterior RA gain-of-
function phenotype induced by the enhanced RA signaling is
epistatic to Cyp26a1 function. To determine if increased cyp26a1
expression alone is sufﬁcient to produce a loss of RA signaling
phenotypes comparable to what we observe with vp-rar mRNA
injection, we injected cyp26a1 mRNA at previously reported doses
(Kudoh et al., 2002). However, we did not observe phenotypes at
any stages that were indicative of a strong loss of RA signaling or
effects on the RA sensor line Tg(βactin:GDBD-RLBD);(UAS:EGFP) at
24 hpf (Supplemental Fig. 3). While RA signaling levels were not
strongly affected, expression of the RA synthesizing enzymes
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embryos (Supplemental Fig. 3), suggesting the enhanced expres-
sion of Cyp26a1 alone initiates compensatory feedback that pre-
vents a signiﬁcant loss in RA signaling. Altogether, these results
indicate that Cyp26a1 is necessary, but not alone sufﬁcient, for the
loss of embryonic RA signaling that follows enhanced RA signaling.
3.3. Modulation of Cyp26a1 can have cell non-autonomous effects
on RA levels
The mechanism by which Cyp26 enzymes control RA in the
environment has been disputed for many years (Hernandez et al.,
2007; Sirbu et al., 2005; White et al., 2007; White and Schilling,
2008). Although Cyp26 enzymes are believed to act as a sink for
RA, evidence supporting or refuting a strictly cell autonomous role
in development has yet to be directly tested. Because our resultsFig. 6. Cyp26a1 has cell non-autonomous consequences on RA signaling levels within
transplanted into WT hosts injected with mrfp mRNA have EGFP expression in the noto
transplanted vp-rarmRNA injected hosts with mrfpmRNA have severely dampened GFP
indicate statistically different from controls (po0.05) using a modiﬁed chi-square test.suggest that increased cyp26a1 expression is required after excess
RA signaling to create a deﬁciency of embryonic RA, we wanted to
exploit this observation and determined if Cyp26a1 can have cell
non-autonomous effects on RA levels within the local environ-
ment. We ﬁrst performed blastula transplantation experiments
using Tg(βactin:GDBD-RLBD);(UAS:EGFP) RA sensor embryos as
donors and WT or vp-rar mRNA injected embryos as hosts. We
found that RA sensor donor cells transplanted into WT hosts
consistently exhibited robust GFP expression when donor cells
gave rise to notochord or neural tissue in the trunk ( Fig. 6A–A3, C–
C3, E). Conversely, RA sensor donor cells transplanted into vp-rar
mRNA-injected hosts had dramatically dampened or absent GFP
expression, despite giving rise to notochord or neural tissue in a
region of the embryo that would normally express GFP (Fig. 6B–
B3, D–D3, E), which suggests the vp-rar expression can promote
cell non-autonomous loss of RA signaling. Next, to determine if thethe local environment. (A–A3, C–C3) Tg(βactin:GDBD-RLBD);(UAS:EGFP) donor cells
chord and spinal cord. (B–B3, D–D3) Tg(βactin:GDBD-RLBD);(UAS:EGFP) donor cells
expression. (E) Table showing summary of blastula transplantation results. Asterisks
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on Cyp26a1, we transplanted RA sensor donor cells into WT hosts
or hosts co-injected with vp-rar mRNA and previously character-
ized cyp26a1 MOs (D'Aniello et al., 2013; Rydeen and Waxman,
2014). In contrast to when RA sensor cells were transplanted into
vp-rar mRNA injected hosts, we found that depletion of Cyp26a1
in vp-rar mRNA injected host embryos results in RA sensor donor
cells with robust GFP expression (Fig. 6E and Supplemental Fig. 4).
A series of control experiments also demonstrated that RA sensor
donors transplanted into Cyp26a1 deﬁcient host embryos have
GFP expression, as would be predicted (Fig. 6E and Supplemental
Fig. 5). Lastly, to exclude the possibility that cyp26a1 expression
was being induced cell non-autonomously in the RA sensor donor
cells when transplanted into vp-rar mRNA injected hosts, we
transplanted Cyp26a1 deﬁcient RA sensor donor cells into either
WT or vp-rar mRNA injected hosts. We found that Cyp26a1 deﬁ-
cient donor cells transplanted into vp-rar mRNA injected hosts
lacked GFP expression (Fig.6E and Supplemental Fig. 6). Alto-
gether, our data suggest that Cyp26a1 can act as a sink and have
cell non-autonomous consequences on the amount of RA in the
local environment.4. Discussion
In this paper, we examined two fundamental aspects of em-
bryonic RA signaling in vertebrates. First, we examined how ter-
atogenic levels of RA signaling promote feedback gain- and loss-
of-function phenotypes in vertebrates. In zebraﬁsh embryos, we
found that enhancing RA signaling, using an RA-responsive hy-
peractive RAR to bolster the signaling from endogenous RA, in-
itiated a seemingly straightforward feedback mechanism that
dramatically induced Cyp26a1, which in turn is required to cause
loss of RA signaling phenotypes due to the depletion of embryonic
RA. Second, we found that in this context Cyp26a1 is required for
cell non-autonomous loss of RA in the local environment, pre-
sumably through acting a sink for RA that limits the amount of RA
exposure to neighboring cells.
We have explicitly examined a mechanism underlying how
teratogenic levels of RA signaling can lead to contradictory phe-
notypes indicative of both gain and loss of RA signaling. While
previous studies found RA supplementation after the initial pulse
of RA to the mother was able to partially restore improper kidney
speciﬁcation in mouse embryos (Lee et al., 2012), the effectors that
cause the loss of RA signaling in the mouse embryo under these
conditions were not speciﬁcally determined. Our data are con-
sistent with a model where temporal differences in embryonic
patterning are affected by converse ﬂuctuations in RA signaling.
We infer that injecting or inducing the hyperactive RAR results in
bursts of enhanced RA signaling, similar to teratogenic pulses of
RA treatment in mouse embryos (Waxman and Yelon, 2011),
which initiates early RA responsive genes. Furthermore, since
more anterior tissues are speciﬁed ﬁrst, loss of midbrain and
anterior hindbrain speciﬁcation is consistent with effects from an
initial increase in RA signaling (Cai et al., 2012; Hernandez et al.,
2007; Maves and Kimmel, 2005; White and Schilling, 2008).
However, the initial burst of RA signaling also induces excessive
negative feedback that turns off RA signaling in the subsequently
patterned, adjacent posterior tissues, which is reﬂected in phe-
notypes including increased cardiomyocyte speciﬁcation and loss
of hoxb5b expression. Together, these ﬁnding suggest that the in-
creased RA signaling is rapidly sequestered and metabolized be-
tween patterning of the hindbrain and the cardiac ﬁeld to yield
opposing phenotypes. Similarly, in the RA treated mice, loss of
function defects were observed in the more posterior structures
such as the kidneys (Lee et al., 2012). It is tempting to speculatethat our results demonstrate the increased cyp26a1 expression as a
result of enhanced RA signaling is potentially the sole mechanism
responsible for the loss of RA signaling. However, overexpression
of cyp26a1 mRNA in zebraﬁsh embryos elicits relatively modest
effects on patterning. The simplest interpretation of this result is
that increased Cyp26a1 is required for the loss of RA signaling, but
is not sufﬁcient alone to elicit a clearing and loss of RA signaling.
One possibility is that the repression of rdh10a and aldh1a2 ex-
pression sensitizes embryos to increased Cyp26a1 expression. Al-
ternatively, Cyp26a1 may be the primary contributor to a loss of
RA signaling, but overexpression of cyp26a1 mRNA alone cannot
fully recapitulate the temporal cascade initiated from excess RA
signaling or it initiates feedback that compensates for the loss of
RA.
Despite the overtly conserved phenotypic trends in response to
enhanced RA signaling in vertebrate embryos, the temporal re-
sponses of RA metabolic machinery expression in zebraﬁsh con-
trast somewhat with what was reported in the mouse. It was
found that a single dose of RA in the mouse can lead to transient
increases in Cyp26 enzymes but prolonged decreases in Aldh1a2
expression (Lee et al., 2012). In contrast to what was found in the
mouse, we observed that there was prolonged cyp26a1 expression
and more transient loss of RA producing enzyme expression in
zebraﬁsh embryos. One reason for the differences in transcrip-
tional response of the expression of RA metabolic machinery be-
tween species may be explained by the differing techniques used
to transiently increase RA signaling. However, we do not presently
think this is the case as cyp26a1, aldh1a2, and rdh10a expression
respond similarly to RA treatment (D'Aniello et al., 2013; Feng
et al., 2010). Another possible reason for the observed differences
is the developmental stages of the RA signaling insult. In Lee et al.
(2012), a singular RA treatment was given to a pregnant damwhen
the embryos were at E9.0. The RA feedback response was then
measured in the embryos at E9.5 through E12.0. Here, we pri-
marily examined the effects after injection of zebraﬁsh embryos at
the 1-cell stage with hyperactive rar mRNA and measured the re-
sponse over the ﬁrst 24 h of development. Therefore, the murine
embryos received the teratogenic RA signaling at a comparably
later developmental stage. While we found that embryos with
heat-shock induced vp-rar expression beginning at 24 hpf, a time
point comparable to murine E9.0, had a loss of embryonic RA si-
milar to injection earlier, we did not determine if the temporal
responses of the RA metabolic machinery are different than earlier
stages over a long period of time. It is also plausible that perhaps
the temporal responses of the RA metabolic machinery to en-
hanced RA have changed in response to inherent differences in
mammalian and teleost embryos, such as the rate of development.
Although previous work has demonstrated that the dynamic re-
sponsiveness of cyp26a1 to RA in vertebrates is conveyed through
co-operativity between 3 conserved RAREs within the cyp26a1
promoter (Hu et al., 2008; Li et al., 2012; Loudig et al., 2000, 2005),
changes in the cyp26a1 promoters that account for temporal dif-
ferences in responsiveness between vertebrates have not been
investigated. Therefore, although teratogenic levels of RA signaling
may elicit slightly different temporal responses of RA metabolic
machinery expression in vertebrate embryos, our results suggest
that the feedback ultimately leads to congenital defects from a loss
of embryonic RA signaling.
Our results also have implications for how RA gradients are
formed within vertebrate embryos. Although Cyp26 enzymes are
necessary for negative feedback believed to play a role in shaping
the embryonic RA gradient (Cai et al., 2012; White et al., 2007;
White and Schilling, 2008), the cellular mechanism by which
Cyp26 enzymes control RA in the local environment has been
greatly debated. There have been two prevailing models for how
Cyp26 enzymes functions to shape the RA gradient. First, Cyp26
A. Rydeen et al. / Developmental Biology 405 (2015) 47–5554enzymes play strictly cell autonomous roles that limit cellular RA
levels and RA signaling. Second, Cyp26 enzymes have cell auton-
omous and cell non-autonomous consequences on RA levels and
signaling that shape the gradient. Recent studies from our lab and
others have suggested that loss of Cyp26 enzymes may lead to
increased RA signaling in neighboring cells (Rydeen and Waxman,
2014; White et al., 2007). However, until now there has been no
direct evidence supporting or refuting a strictly cell autonomous
role of Cyp26 expression in controlling embryonic RA signaling.
Thus, our blastula transplantation experiments incorporating
transgenic RA sensor lines provide the ﬁrst direct evidence that
Cyp26 enzymes is required to as a sink that removes RA from the
local environment, limiting the amount of RA signaling exposure
to neighboring cells. Altogether, our data suggest that modulation
of Cyp26 enzyme expression can have cell non-autonomous con-
sequences on RA signaling within neighboring tissues, which
provide support for a model where dynamic Cyp26a1 expression
helps to shape the embryonic RA gradient through rapid RA-re-
sponsive ﬂuctuations (White et al., 2007).
In conclusion, our study enhances our understanding of how
RA feedback mechanisms respond to ﬂuctuation in RA signaling
levels and can adversely affect vertebrate development. These
ﬁndings will potentially have implications for developing new
strategies aimed at preventing defects found in RA embryopathies
and other disease contexts where there is dysregulation of RA
signaling through modulation of Cyp26 activity.Acknowledgments
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